CVA Family Office’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6
Closed -$47 1410
2024
Q4
$47 Hold
6
﹤0.01% 1282
2024
Q3
$19 Hold
6
﹤0.01% 1266
2024
Q2
$17 Hold
6
﹤0.01% 1275
2024
Q1
$95 Hold
6
﹤0.01% 1046
2023
Q4
$118 Buy
+6
New +$104 ﹤0.01% 1035
2023
Q3
Sell
-6
Closed -$175 388
2023
Q2
$175 Hold
6
﹤0.01% 1002
2023
Q1
$169 Hold
6
﹤0.01% 972
2022
Q4
$111 Hold
6
﹤0.01% 938
2022
Q3
$0 Hold
6
﹤0.01% 881
2022
Q2
$0 Hold
6
﹤0.01% 919
2022
Q1
$0 Hold
6
﹤0.01% 954
2021
Q4
$0 Buy
+6
New +$529 ﹤0.01% 902
2021
Q3
Sell
-6
Closed -$1K 470
2021
Q2
$1K Buy
+6
New +$590 ﹤0.01% 909

Other funds holding CRNC

CVA Family Office's CRNC Position: Q1 2025 in Review

CVA Family Office sold out of Cerence (CRNC) in Q1 2025, closing a stake of 6 shares — an estimated $47 sold.

CVA Family Office first reported a position in CRNC in Q2 2021 and held it in 13 quarters. The position peaked at $1K in Q2 2021. 178 funds tracked by Wall St. Rank hold CRNC as of Q1 2025.

  • CVA Family Office reported no remaining Cerence position as of Q1 2025 after selling out during the quarter.
  • CVA Family Office sold 6 Cerence shares in Q1 2025, an estimated $47.
  • CVA Family Office first reported a position in Cerence in Q2 2021 and held it in 13 quarters.
  • CVA Family Office's Cerence position peaked at $1K in Q2 2021.
  • 178 funds tracked by Wall St. Rank held Cerence as of Q1 2025.

Based on CVA Family Office's 13F filing for Q1 2025, filed 16 Apr 2025.